| Literature DB >> 29941645 |
Yi Yao1,2, Kai Wu3, Mingxing Xu3, Yan Yang3, Yijing Zhang1,2, Wenjing Yang1,2, Ronghua Shang1,2, Weixing Du1,2, Huabing Tan1,2, Jiangtao Chen4, Min Lin5, Jian Li6,2.
Abstract
Antimalarial drug resistance developed in Plasmodium falciparum has become a problem for malaria control. Evaluation of drug resistance is the first step for effective malaria control. In this study, we investigated the gene mutations of P. falciparum using blood samples from returned Chinese migrant workers in order to identify drug resistance-associated molecular markers. These workers returned from Africa and Southeast Asia (SEA) during 2011 to 2016. Polymorphisms in pfcrt, pfmdr1, and k13-propeller genes and the haplotype patterns of Pfcrt and Pfmdr1 were analyzed. The results showed the presence of four haplotypes of Pfcrt codons 72 to 76, including CVMNK (wild type), SVMNT and CVIET (mutation types), and CV M/I N/E K/T (mixed type), with 50.57%, 1.14%, 25.00%, and 23.30% prevalence, respectively. For Pfmdr1, N86Y (22.28%) and Y184F (60.01%) were the main prevalent mutations (mutations are underlined). The prevalence of mutation at position 550, 561, 575, and 589 of K13-propeller were 1.09%, 0.54%, 0.54%, and 0.54%, respectively. These data suggested that Pfcrt, Pfmdr1, and K13-propeller polymorphisms are potential markers to assess drug resistance of P. falciparum in China, Africa, and SEA.Entities:
Keywords: Plasmodium falciparum; antimalarial drug; artemisinin; haplotype; polymorphism; resistance
Mesh:
Substances:
Year: 2018 PMID: 29941645 PMCID: PMC6125563 DOI: 10.1128/AAC.02387-17
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191